Shareholders' Equity (Details) - Schedule of activity in warrants - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Schedule of activity in warrants [Abstract] | ||
| Warrants, Balance (in Shares) | 8,649,625 | 6,669,274 |
| Weighted Average Remaining Term (Years), Balance | 4 years 2 months 23 days | |
| Weighted Average Exercise Price, Balance | $ 4.6 | $ 5.38 |
| Average Intrinsic Value, Balance | $ 0.02 | $ 0.03 |
| Warrants,Issued (in Shares) | 53,146 | 2,206,705 |
| Weighted Average Exercise Price,Issued | $ 2.26 | $ 1.98 |
| Average Intrinsic Value Issued | ||
| Warrants, Exercised (in Shares) | (712,500) | (226,354) |
| Weighted Average Exercise Price, Exercised | $ 2 | $ 1.99 |
| Average Intrinsic Value, Exercised | ||
| Warrants, Balance (in Shares) | 7,990,271 | 8,649,625 |
| Weighted Average Remaining Term (Years), Balance | 2 years 7 months 17 days | 3 years 5 months 15 days |
| Weighted Average Exercise Price, Balance | $ 4.82 | $ 4.6 |
| Average Intrinsic Value, Balance | $ 0.14 | $ 0.02 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Average Intrinsic Value, Exercised. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Outstanding weighted average remaining contractual term. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Remaining Term (Years), Balance. No definition available.
|
| X | ||||||||||
- Definition Per share or unit weighted-average intrinsic value of award granted under share-based payment arrangement. Excludes share and unit options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. No definition available.
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. No definition available.
|